MedPath

Environmental Health Effects on Your Physiology

Completed
Conditions
Obesity
Registration Number
NCT03986814
Lead Sponsor
University of Colorado, Boulder
Brief Summary

This study evaluates the associations between exposure to air pollutants, green space, and the gut microbiome and metabolome.

Detailed Description

A rapidly evolving field of study suggests a link between the gut microbiome and fecal metabolome with obesity. Recent studies show that environmental exposures, such as ambient air pollution (AAP) exposure can affect gut bacteria and modify risk for obesity. Additionally, proximity to green space has been shown to reduce exposure to air pollutants and increase gut microbial diversity. The investigator's preliminary work has shown that near-roadway air pollution exposure was positively correlated with gut microbial taxa that have been linked with obesity. These findings suggest that air pollution exposure may increase susceptibility to obesity through alterations in the composition and function of the gut microbiome. Despite this, no studies have systematically examined the impact of air pollutants and green space on the gut microbiome and metabolome among adolescents. The overall goal of this research is to determine whether exposure to air pollutants and/or green space affect the gut microbiome and metabolome in young adults residing in Denver, Colorado. This study will examine residential-based estimates of air pollution exposure and green space and also perform detailed gut microbial and metabolite profiling in 100 adolescent and young adults.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
92
Inclusion Criteria
  • The participant population includes young adults (18-25 years of age) who live in Denver, Colorado.
Exclusion Criteria
  • Exclusion criteria include physical, mental, or cognitive disability that prevents participation
  • Current incarceration
  • Antibiotic usage in the previous month
  • Pregnant or nursing
  • Non-English speaking
  • Any medical conditions known to affect body composition, insulin secretion, or the gut microbiota (i.e., type 1 or 2 diabetes, intestinal bowel disease, Crohn's Disease, kidney disease, heart disease, autoimmune disease).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body mass index (BMI)Measured once at baseline visit date

Weight and height will be combined to report BMI in kg/m\^2

Gut MicrobiomeMeasured once at baseline visit date

16S rRNA and Shotgun Sequencing

Fecal MetabolomeMeasured once at baseline visit date

Targeted and/or Un-targeted Metabolomics

Body CompositionMeasured once at baseline visit date

Waist and hip measurements will be taken

Secondary Outcome Measures
NameTimeMethod
Physical ActivityMeasured once at baseline

International Physical Activity Questionnaire

Fasting InsulinMeasured once at baseline

Fasting insulin (uU/mL)

Air PollutionOne year before baseline visit date

Modeled residential exposure to air pollution

Green SpaceOne year before baseline visit date

Modeled residential exposure to green space

Serum MetabolomeMeasured once at baseline visit date

Targeted and/or Un-targeted Metabolomics

DietMeasured once at baseline

Automated Self-Administered 24-Hour (ASA24)

Fasting GlucoseMeasured once at baseline

Fasting Glucose (mg/dl)

Trial Locations

Locations (1)

Clinical and Translational Research Center

🇺🇸

Boulder, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath